BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou M, Chan EW, Hai JJ, Wong CK, Lau YM, Huang D, Lam CC, Tam CCF, Wong YTA, Yung SYA, Chan KWK, Feng Y, Tan N, Chen JY, Yung CY, Lee KL, Choi CW, Lam H, Ng A, Fan K, Jim MH, Yiu KH, Yan BP, Siu CW. Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study. BMJ Open 2020;10:e038194. [PMID: 32978200 DOI: 10.1136/bmjopen-2020-038194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo G, Liang S, Guan Z, Zhu K. Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1070806] [Reference Citation Analysis]
2 Sadeghipour P, Farrashi M, De Caterina R. Response to “non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial”. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.04.075] [Reference Citation Analysis]
3 Fanaroff AC, Vora AN, Lopes RD. Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease. European Heart Journal Supplements 2022;24:A19-31. [DOI: 10.1093/eurheartj/suab151] [Reference Citation Analysis]
4 Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation. J Arrhythm 2021;37:1389-426. [PMID: 34887945 DOI: 10.1002/joa3.12652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Bitar YSL, Duraes AR, Roever L, Gomes Neto M, Lins-Kusterer L, Bocchi EA. Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Cardiovasc Med 2021;8:712585. [PMID: 34631818 DOI: 10.3389/fcvm.2021.712585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]